HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shao-Long Li Selected Research

Sorafenib (BAY 43-9006)

10/2022Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shao-Long Li Research Topics

Disease

5Hepatocellular Carcinoma (Hepatoma)
10/2022 - 07/2016
2Neoplasms (Cancer)
02/2019 - 07/2016
1Atrial Fibrillation
01/2021
1Intervertebral Disc Degeneration
01/2021
1Hepatitis B
02/2019

Drug/Important Bio-Agent (IBA)

1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2022
1Fluorouracil (Carac)FDA LinkGeneric
10/2022
1Leucovorin (Folinic Acid)FDA Link
10/2022
1Sorafenib (BAY 43-9006)FDA Link
10/2022
1LigandsIBA
02/2019
1CytokinesIBA
07/2016
1Indicators and Reagents (Reagents)IBA
07/2016
1B7-H1 AntigenIBA
07/2016

Therapy/Procedure

2Therapeutics
01/2021 - 02/2019
2Radiofrequency Ablation
01/2021 - 01/2017
1Drug Therapy (Chemotherapy)
10/2022
1Catheter Ablation
01/2021
1Immunotherapy
02/2019